LIXT Wutah pendapatan triwulanan Lixte Biotechnology

Simbol lan logo merek Lixte Biotechnology, Inc. (LIXT)

The credit quality potential of Lixte Biotechnology (LIXT) is based on the development of drugs that increase tumor sensitivity to standard treatment. This quarterly revenue chart demonstrates price stability, where this metric equals 0.00. Financial stability is ensured by a patent lock-in with scientific centers and a strategic alliance with the U.S. National Cancer Institute to conduct safe trials according to FDA standards.

Lixte Biotechnology, Inc. (LIXT) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 06.07.2026

Lixte Biotechnology Holdings, Inc. (LIXT) - rincian metrik lan laporan keuangan

Barang unggulan lixte.com

The specific nature of Lixte Biotechnology (LIXT), which relies on international scientific exchange and IT infrastructure, leaves the business vulnerable to geopolitical barriers in the development of oncology drugs. This price action is reflected in the quarterly revenue growth rate, which measures the pace of sales changes relative to the previous period, allowing investors to use this chart to differentiate fundamentally sustainable development trends from temporary market fluctuations.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|CTXR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CLRB|Wutah pendapatan triwulanan BioLineRx Corporation (BLRX)|Wutah pendapatan kuartal marang kuartal Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Dinamika pendapatan kuartal marang kuartal|KZIA: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Silexion Therapeutics|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)